| NCT06603077 | A Study to Evaluate the Efficacy and Safety of AVTX-009 in Patients With Moderate to Severe Hidradenitis Suppurativa | RECRUITING | PHASE2 | 2024-09-16 | 2026-07 | 2026-06 |
| NCT05288504 | A Study to Evaluate the Safety and Efficacy of AVTX-002 for the Treatment of Poorly Controlled Non-Eosinophilic Asthma. | COMPLETED | PHASE2 | 2022-02-24 | 2023-05-11 | 2023-05-11 |
| NCT04994002 | A Pharmacokinetic, Pharmacodynamic, Safety and Tolerability Study of CERC-006 in Adults With Complex Lymphatic Malformations | WITHDRAWN | PHASE1 | 2021-09-03 | 2022-06 | 2022-06 |
| NCT04671251 | Phase 1b Study of AEVI-007 in Subjects With Relapsed or Refractory Multiple Myeloma | COMPLETED | PHASE1 | 2020-12-15 | 2022-03-30 | 2022-03-30 |
| NCT04412057 | Clinical Trial to Evaluate CERC-002 in Adults With COVID-19 Pneumonia and Acute Lung Injury | COMPLETED | PHASE2 | 2020-07-17 | 2021-01-19 | 2020-12-14 |
| NCT03609619 | PART B: Efficacy and Safety of AEVI-001 in Children and Adolescents With ADHD and Without mGluR Mutations | COMPLETED | PHASE2 | 2018-08-17 | 2018-11-30 | 2018-11-23 |
| NCT03265119 | PART A: Efficacy and Safety of AEVI-001 in Children and Adolescents With ADHD and With mGluR Mutations | COMPLETED | PHASE2 | 2017-08-28 | 2018-10-01 | 2018-09-24 |
| NCT03169894 | Evaluation of the Safety, Tolerability, and Efficacy of MDGN-002 in Adults With Moderate to Severe Active Crohn's Disease or Ulcerative Colitis | TERMINATED | PHASE1 | 2017-07-14 | 2021-10-12 | 2021-09-14 |
| NCT03006367 | Pharmacokinetic and Tolerability Study of NFC-1 in Subjects Aged 6-17 Years With ADHD | COMPLETED | PHASE1 | 2017-01-07 | 2017-03-06 | 2017-02-26 |
| NCT02895906 | Safety and Efficacy Study of NFC-1 in Subjects Aged 12-17 Years With 22q11.2DS & Associated Neuropsychiatric Conditions | COMPLETED | PHASE1 | 2016-11-28 | 2017-04-20 | 2017-04-13 |
| NCT02777931 | Efficacy and Safety of NFC-1 in Adolescents With Genetic Disorders Impacting mGluR and ADHD | COMPLETED | PHASE2, PHASE3 | 2016-06 | 2017-02-17 | 2017-02-10 |
| NCT02468414 | TARGTEPO Treatment for Anemia in PD US Trial | TERMINATED | PHASE2 | 2015-06 | 2016-09 | 2016-05 |
| NCT02459236 | A Study of Intermittent Doses of CERC-301 in MDD | COMPLETED | PHASE2 | 2015-06 | 2016-12 | 2016-09 |
| NCT01941043 | A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment | COMPLETED | PHASE2 | 2013-11 | 2014-10 | 2014-09 |
| NCT01703923 | An Exploratory Study of FP01 Lozenges in Subjects With Chronic Refractory Cough | COMPLETED | PHASE2 | 2012-11 | 2013-09 | 2013-09 |
| NCT01597349 | Antitussive Effects of FP01 Lozenges in Subjects With Cough Due to Upper Respiratory Tract Infection | COMPLETED | PHASE2 | 2012-05 | 2012-09 | 2012-09 |
| NCT01579526 | A Single Dose Study to Determine the Safety and Pharmacokinetics of FP01 Lozenges in Healthy Volunteers | COMPLETED | PHASE1 | 2012-04 | 2012-05 | 2012-04 |